0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

A new age in asthma research: study of chemical mediators

William A. Check
JAMA. 1980;244(8):745-747. doi:10.1001/jama.1980.03310080003001.
Text Size: A A A
Published online

ABSTRACT

Thirty-four years of research culminated early this year in both the elucidation of the structure and the in vitro synthesis of slow-reacting substance of anaphylaxis (SRS) by a team of scientists from Boston and Stockholm.

The new information about SRS adds to a rapidly expanding body of knowledge about the natural chemicals that produce asthmatic symptoms. Many experts in this field think that these mediators lead to both allergic and nonallergic asthma, since they originate from mast cells and mast cells respond to many stimuli other than the antibody involved in allergy (IgE). Thus, this work potentially could benefit patients with a wide range of respiratory illnesses.

A second molecule that has been isolated, analyzed, and synthesized in the last year and is believed to be involved in allergic reactions is platelet-activating factor (PAF). Work on SRS has overshadowed progress on PAF, partly because SRS has a longer history—40 years

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();